{"id":9838,"date":"2018-06-14T06:52:36","date_gmt":"2018-06-14T06:52:36","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/macedonian-cultivation-facility-standardize-on-heliospectra-led-technology-2\/"},"modified":"2018-06-14T06:52:36","modified_gmt":"2018-06-14T06:52:36","slug":"macedonian-cultivation-facility-standardize-on-heliospectra-led-technology-2","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/nl\/blog\/mfn_nieuws\/macedonian-cultivation-facility-standardize-on-heliospectra-led-technology-2\/","title":{"rendered":"Macedonische kweekfaciliteit standaardiseert op Heliospectra LED-technologie"},"content":{"rendered":"
Kweker van medicinale cannabis breidt verder uit en investeert in Heliospectra LED-verlichtingsoplossingen om medicinale profielen en kwaliteit te standaardiseren<\/p>\n

(GOTHENBURG, Sweden\/SAN FRANCISCO, CA, June 14, 2018 –<\/p>\n

Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), een wereldleider in intelligente verlichtingstechnologie voor kassen en gecontroleerde plantengroeiomgevingen, kondigt een nieuwe order aan van Medical 420 DOO, een ultramoderne medicinale cannabisfaciliteit in Macedoni\u00eb. De kweker is de productie snel aan het opschalen en blijft standaardiseren op Heliospectra LED-verlichtingsoplossingen. De order heeft een waarde van ongeveer 3 728 000 SEK ($432,643 USD).<\/strong><\/div>\n

“With Heliospectra we have been able to standardize our products to the highest quality while increasing yields. As the medical market is growing, our operations are expanding and we remain entirely committed to supplying our customers and patients with consistent medical products and effective treatments,” said Tony Gasovski, owner and founder of Medical 420.<\/span><\/p>\n

The indoor controlled environment facility is currently equipped with Heliospectra Eos™ (formerly E60) series, the new order also implements Heliospectra’s intelligent Elixia™ (formerly LX60) series to add automation and continue to improve quality, accelerate harvest cycles <\/span>and production cycles while delivering consistent yields.<\/span><\/p>\n

“Medical 420 is achieving rapid, positive ROI with the simple, yet powerful Heliospectra solution,” said Ali Ahmadian, CEO of Heliospectra. He added, “We’re pleased to support the Medical 420 team in achieving consistently high-quality product profiles, harvest after harvest.”<\/span> <\/p>\n

The order will ship and be visible in the <\/span>accounts during Q3 and Q4. <\/span><\/p>\n

\n

Investeerdersrelaties:<\/span><\/strong><\/span><\/p>\n

Ali Ahmadian, CEO van Heliospectra | +46 (0)72 203 6344 | <\/span>ir@heliospectra.com<\/span><\/a><\/p>\n

Redeye is Heliospectra Certified Advisor voor Nasdaq First North.<\/span> <\/span>www.redeye.se<\/span><\/a><\/p>\n

http:\/\/www.heliospectra.com<\/a><\/span><\/p>\n<\/div>\n